Yves Auberson is the executive director of Global Discovery Chemistry at Novartis Institutes for BioMedical Research. Auberson’s team is responsible for designing and synthesizing drugs that are safe for patients suffering from diseases such as epilepsy and Alzheimer’s. In this video interview, Auberson explains what satisfies him the most about working in chemistry and the challenges he faces in medicinal chemistry.
Want more stories like this delivered to your inbox?
Sign up for our newsletter to receive a selection of stories related to your favorite topics.